Livzon Pharmaceutical Group Incorporated operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Livzon Pharmaceutical Group Incorporated with three other
companies in this sector in China:
Chongqing Taiji Industry (Group)
sales of 7.16 billion Chinese Renmimbi [US$1.04 billion]
of which 56%
Huapont-Nutrichem Co Ltd
(6.17 billion Chinese Renmimbi [US$896.20 million]
of which 67%
was Agricultural Business), and
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
(7.08 billion Chinese Renmimbi [US$1.03 billion]
of which 62%
was Chinese Medicine).
During the year ended December of 2015, sales at
Livzon Pharmaceutical Group Incorporated were 6.62 billion Chinese Renmimbi (US$961.89 million).
increase of 19.4%
versus 2014, when the company's sales were 5.54 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Livzon Pharmaceutical Group Incorporated
(and since 2010, sales have increased a total of 143%).
Sales of Materials saw an increase
33.1% in 2015, from
1.14 billion Chinese Renmimbi to 1.52 billion Chinese Renmimbi.
Not all segments of Livzon Pharmaceutical Group Incorporated experienced an increase in sales in 2015:
sales of Other fell 49.2% to 5.69 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).